These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9315115)

  • 1. Suppression of delayed-type contact sensitivity in the murine oral mucosa by prior intragastric administration of hapten.
    Ahlfors E; Czerkinsky C
    Scand J Immunol; 1997 Sep; 46(3):268-73. PubMed ID: 9315115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental T cell-mediated inflammatory reactions in the murine oral mucosa. II. Immunohistochemical characterization of resident and infiltrating cells.
    Ahlfors E; Jonsson R; Czerkinsky C
    Clin Exp Immunol; 1996 May; 104(2):297-305. PubMed ID: 8625524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed-type hypersensitivity reactions at mucosal surfaces.
    Ahlfors E; Czerkinsky C
    Clin Exp Immunol; 1991 Dec; 86(3):449-56. PubMed ID: 1747952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells.
    Desvignes C; Etchart N; Kehren J; Akiba I; Nicolas JF; Kaiserlian D
    J Immunol; 2000 Mar; 164(5):2515-22. PubMed ID: 10679089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact sensitivity reactions in the oral mucosa.
    Ahlfors EE; Lyberg T
    Acta Odontol Scand; 2001 Aug; 59(4):248-54. PubMed ID: 11570529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific regulation of oral mucosa-recruiting CD8
    Hirunwidchayarat W; Furusawa E; Kang S; Ohno T; Takeuchi S; Rungsiyanont S; Azuma M
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1294-1300. PubMed ID: 28687491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of contact sensitivity and cell-mediated lympholysis by oral administration of hapten is caused by different mechanisms.
    Gautam SC; Battisto JR
    Cell Immunol; 1983 Jun; 78(2):295-304. PubMed ID: 6861205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity.
    Gautam SC; Battisto JR
    J Immunol; 1985 Nov; 135(5):2975-83. PubMed ID: 2413107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of local tissue and regional lymph node IL-2 and IFN-gamma responses in experimental oral mucosa and skin contact sensitivity in mice.
    Ahlfors EE; Lyberg T
    Scand J Immunol; 2010 Jul; 72(1):8-14. PubMed ID: 20591070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice.
    Desvignes C; Bour H; Nicolas JF; Kaiserlian D
    Eur J Immunol; 1996 Aug; 26(8):1756-61. PubMed ID: 8765017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light microscopic study of experimental cell-mediated immunity in rat oral mucosa.
    Ahlfors EE; Larsson PA
    Scand J Dent Res; 1984 Dec; 92(6):549-56. PubMed ID: 6597539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The murine buccal mucosa is an inductive site for priming class I-restricted CD8+ effector T cells in vivo.
    Desvignes C; Estèves F; Etchart N; Bella C; Czerkinsky C; Kaiserlian D
    Clin Exp Immunol; 1998 Sep; 113(3):386-93. PubMed ID: 9737667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GammadeltaT cells regulate the development of hapten-specific CD8+ effector T cells in contact hypersensitivity responses.
    Guan H; Zu G; Slater M; Elmets C; Xu H
    J Invest Dermatol; 2002 Jul; 119(1):137-42. PubMed ID: 12164936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population.
    Gautam SC; Chikkala NF; Battisto JR
    Cell Immunol; 1990 Feb; 125(2):437-48. PubMed ID: 2137034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells.
    Xu H; Banerjee A; Dilulio NA; Fairchild RL
    J Immunol; 1997 May; 158(10):4721-8. PubMed ID: 9144485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD.
    Saint-Mezard P; Krasteva M; Chavagnac C; Bosset S; Akiba H; Kehren J; Kanitakis J; Kaiserlian D; Nicolas JF; Berard F
    J Invest Dermatol; 2003 Apr; 120(4):641-7. PubMed ID: 12648229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
    Ptak W; Bereta M; Ptak M; Askenase PW
    J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism.
    Gorbachev AV; Fairchild RL
    J Immunol; 2004 Feb; 172(4):2286-95. PubMed ID: 14764697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid dendritic cells mediate oral tolerance.
    Goubier A; Dubois B; Gheit H; Joubert G; Villard-Truc F; Asselin-Paturel C; Trinchieri G; Kaiserlian D
    Immunity; 2008 Sep; 29(3):464-75. PubMed ID: 18789731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.